This finding suggests that the glycosylation of PCOLCE is necessary for the promotion of osteosarcoma metastasis, and that targeting PCOLCE or its regulator Twist Family BHLH Transcription Factor 1 (Twist1) could be beneficial for metastatic osteosarcoma therapy [173]. This evidence concerns the gene TWIST1 and osteosarcoma.